The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review (Q40178673)

18 September 2017

1 reference

title

The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review (English)

1 reference

18 September 2017

The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review (English)

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

11 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

11 October 2023

author name string

J. P. Raynaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

C. Bonne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

M. Moguilewsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

F. A. Lefebvre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

A. Bélanger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

F. Labrie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374639

11 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6374639

11 October 2023

publication date

1 January 1984

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990050307

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.2990050307

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

11 October 2023

1 reference

18 September 2017

5

1 reference

18 September 2017

3

1 reference

18 September 2017

299-311

1 reference

Receptor Binding as a Tool in the Development of New Bioactive Steroids

18 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.2990050307

Screening for anti-hormones by receptor studies

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

The relevance of kinetic parameters in the determination of specific binding to the estrogen receptor

11 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Steroid flexibility and receptor specificity

11 October 2023

7

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Assay of androgen binding sites by exchange with methyltrienolone (R 1881)

11 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

11 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

On the Mechanism of the Anti-androgenic Action ofFlutamide (α-α-α-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide)in the Rat

11 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues

11 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Selective Effect of Androgens on LH and FSH Release in Anterior Pituitary Cells in Culture

11 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Steroid hormone receptors and pharmacology

11 October 2023

23

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.

11 October 2023

24

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat

11 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat

11 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens

11 October 2023

30

1 reference

https://api.crossref.org/works/10.1002/PROS.2990050307

11 October 2023

Identifiers

1 reference

18 September 2017

1 reference